The Patterson Perspective

As an untreatable Ebola strain grips East Africa, a $250k donation from crypto exchange Binance offers a lifeline. But can corporate aid plug the gaps?

A Swedish firm's novel cell therapy is the first of its kind in Europe, challenging the grim prognosis of pancreatic cancer and testing a new model for biotech.

Caterpillar's 32nd straight dividend hike is a win for investors, but it's also a powerful signal about the health of the global economy and its new engine: AI.

Frasers Group's €1.98 billion offer for Hugo Boss is more than a deal; it's a strategic gambit that tests the value of a legacy German brand.

As digital fraud grows, one company's rise to 'Leader' status, fueled entirely by user reviews, reveals what businesses truly need to secure the system.

A new US-UK partnership bets on 'agentic AI' to unlock data trapped in public sector systems. Is this the key to modernization or another layer of complexity?

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

A new app, PlayerU, launches with an AI coach and a Hall of Fame partner, aiming to dominate the booming pickleball market. But what is the true cost of entry?

Duracell's unprecedented move to print Lionel Messi's tattoos on its batteries is more than marketing; it's a play to redefine the humble battery.

As adtech giant adjoe bets big on Latin America, its value-exchange model signals a structural shift away from intrusive ads toward a new digital contract.

A new campaign warns that declining public data is a crisis as urgent as failing roads, threatening the very foundation of our democracy. Is it too late?

A new partnership brings instant $50,000 credit lines to cruise ship jewelry stores, blurring the line between vacation bliss and high-stakes finance.

A new platform aims to make buying travel insurance as easy as asking an AI. But what does this new layer of automation mean for the systems we rely on?

A massive Q1 profit, driven by a one-time deal, conceals a revenue drop and a critical systems failure, raising questions about the retailer’s core health.

As enterprises grapple with the risks of AI, a new UK firm is betting that control, not just capability, is the key to unlocking its true value.

VENU's $50M sale-leaseback fuels a rapid expansion. But is its innovative financial model a new blueprint for growth or a high-stakes bet on the future?

A Cayman Islands exchange is offering a headline-grabbing 60% yield on Stellar. We dissect the math, the risk, and why this is about more than just a promo.

As AI reshapes the market, Culturati Research’s new study bets on a hybrid model, combining machine learning with human expertise to navigate a fragmented world.

Struggling biotech Tempest Therapeutics adds finance and medical heavyweights to its board. Is this a strategic reset or a last-ditch effort to survive?

As Chair Ilona Haaijer announces her 2026 departure, Corbion's seamless succession plan reveals a masterclass in governance and strategic continuity.